These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 3374357

  • 1. Immobilized heparin lyase system for blood deheparinization.
    Bernstein H, Yang VC, Cooney CL, Langer R.
    Methods Enzymol; 1988; 137():515-29. PubMed ID: 3374357
    [No Abstract] [Full Text] [Related]

  • 2. An immobilized microbial heparinase for blood deheparinization.
    Linhardt RJ, Cooney CL, Tapper D, Zannetos CA, Larsen AK, Langer R.
    Appl Biochem Biotechnol; 1984 Feb; 9(1):41-55. PubMed ID: 6476820
    [Abstract] [Full Text] [Related]

  • 3. An enzymatic system for removing heparin in extracorporeal therapy.
    Langer R, Linhardt RJ, Hoffberg S, Larsen AK, Cooney CL, Tapper D, Klein M.
    Science; 1982 Jul 16; 217(4556):261-3. PubMed ID: 7089564
    [Abstract] [Full Text] [Related]

  • 4. Determination of the intrinsic Michaelis constant of immobilized heparinase.
    Lortie R, Broughton R.
    Ann N Y Acad Sci; 1995 Mar 31; 750():58-61. PubMed ID: 7785881
    [No Abstract] [Full Text] [Related]

  • 5. Effect of extracorporeal enzymatic deheparinization on formed blood components.
    Larsen AK, Linhardt RJ, Tapper D, Klein M, Langer R.
    Artif Organs; 1984 May 31; 8(2):198-203. PubMed ID: 6732548
    [Abstract] [Full Text] [Related]

  • 6. Coagulation patterns during deheparinization with immobilized polycation.
    von Segesser LK, Mihailevic T, Tönz M, Leskosek B, von Felten A, Turina M.
    ASAIO J; 1994 May 31; 40(3):M565-9. PubMed ID: 8555578
    [Abstract] [Full Text] [Related]

  • 7. Heparinase immobilization. Characterization and optimization.
    Yang VC, Bernstein H, Langer R.
    Ann N Y Acad Sci; 1988 May 31; 542():515-20. PubMed ID: 3228243
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enzymatic extracorporeal deheparinization: effects of sub-chronic exposure to heparin fragments.
    Larsen AK, Hetelekidis S, Langer R.
    Trans Am Soc Artif Intern Organs; 1984 May 31; 30():298-302. PubMed ID: 6533900
    [No Abstract] [Full Text] [Related]

  • 10. Mode of action of heparin lyase on heparin.
    Linhardt RJ, Fitzgerald GL, Cooney CL, Langer R.
    Biochim Biophys Acta; 1982 Apr 03; 702(2):197-203. PubMed ID: 7082675
    [Abstract] [Full Text] [Related]

  • 11. In vivo activity of microbial heparinase.
    Langer R, Linhardt RJ, Larsen AK, Cooney CL, Tapper D, Klein M.
    Trans Am Soc Artif Intern Organs; 1982 Apr 03; 28():387-90. PubMed ID: 7164268
    [No Abstract] [Full Text] [Related]

  • 12. Isoelectric points of the polysaccharide-degrading enzymes in Flavobacterium heparinum.
    Yang VC, Morgan L, McCarty MT, Langer R.
    Carbohydr Res; 1985 Nov 01; 143():294-9. PubMed ID: 4084918
    [No Abstract] [Full Text] [Related]

  • 13. Sulfur regulation of heparinase and sulfatases in Flavobacterium heparinum.
    Cerbelaud EC, Conway LJ, Galliher PM, Langer RS, Cooney CL.
    Appl Environ Microbiol; 1986 Mar 01; 51(3):640-6. PubMed ID: 3963813
    [Abstract] [Full Text] [Related]

  • 14. Monoclonal antibodies prepared against heparin lyase I and their reactivity toward heparin lyase I, II and III.
    Gu K, Edens RE, Jandik KA, Linhardt RJ.
    Int J Biochem; 1993 Mar 01; 25(3):331-6. PubMed ID: 8462724
    [Abstract] [Full Text] [Related]

  • 15. Ex vivo model of an immobilized-enzyme reactor.
    Bernstein H, Langer R.
    Proc Natl Acad Sci U S A; 1988 Nov 01; 85(22):8751-5. PubMed ID: 3186758
    [Abstract] [Full Text] [Related]

  • 16. New approaches for anticoagulation in extracorporeal therapy.
    Linhardt RJ, Langer R.
    Biomater Artif Cells Artif Organs; 1987 Nov 01; 15(1):91-100. PubMed ID: 2835116
    [Abstract] [Full Text] [Related]

  • 17. Specificity studies on the heparin lyases from Flavobacterium heparinum.
    Desai UR, Wang HM, Linhardt RJ.
    Biochemistry; 1993 Aug 17; 32(32):8140-5. PubMed ID: 8347612
    [Abstract] [Full Text] [Related]

  • 18. Substrate specificity of the heparin lyases from Flavobacterium heparinum.
    Desai UR, Wang HM, Linhardt RJ.
    Arch Biochem Biophys; 1993 Nov 01; 306(2):461-8. PubMed ID: 8215450
    [Abstract] [Full Text] [Related]

  • 19. A novel bioreactor based on suspended particles of agarose-immobilized species.
    Freed LE, Vunjak GV, Drinker PA, Langer R.
    ASAIO Trans; 1988 Nov 01; 34(3):732-8. PubMed ID: 3196592
    [Abstract] [Full Text] [Related]

  • 20. Action pattern of polysaccharide lyases on glycosaminoglycans.
    Jandik KA, Gu K, Linhardt RJ.
    Glycobiology; 1994 Jun 01; 4(3):289-96. PubMed ID: 7949654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.